trihexyphenidyl has been researched along with Movement Disorders in 45 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There are conflicting reports regarding the efficacy of trihexyphenidyl, an anticholinergic drug, for treatment of dystonia in cerebral palsy." | 7.77 | Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis. ( Ben-Pazi, H, 2011) |
| "The clinical efficacy of the trihexyphenidyl was investigated in 100 patients with movement disorders." | 7.67 | Treatment of movement disorders with trihexyphenidyl. ( Gunderson, CH; Jabbari, B; Miller, J; Rosenberg, ML; Scherokman, B, 1989) |
| "There are conflicting reports regarding the efficacy of trihexyphenidyl, an anticholinergic drug, for treatment of dystonia in cerebral palsy." | 3.77 | Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis. ( Ben-Pazi, H, 2011) |
| "The clinical efficacy of the trihexyphenidyl was investigated in 100 patients with movement disorders." | 3.67 | Treatment of movement disorders with trihexyphenidyl. ( Gunderson, CH; Jabbari, B; Miller, J; Rosenberg, ML; Scherokman, B, 1989) |
| "Acute withdrawal is therefore unjustified, but occasional revision of dosage of anti-Parkinsonian drugs is advisable." | 2.64 | Benzhexol and side effects with long-acting fluphenazine therapy. ( Crammer, JL; Grove, L, 1972) |
| "Pediatric movement disorders are a heterogeneous group of symptoms that occur in the context of a large number of different neurological diseases." | 2.42 | Pediatric movement disorders. ( Sanger, TD, 2003) |
| "Classical galactosemia is an autosomal recessive inborn error of metabolism leading to toxic accumulation of galactose and derived metabolites." | 1.39 | Movement disorders in adult patients with classical galactosemia. ( Bhatia, KP; Burke, D; Carecchio, M; Chandrashekar, HS; Edwards, MJ; Footitt, EJ; Kojovic, M; Lachmann, RH; Murphy, E; Parees, I; Rubio-Agusti, I, 2013) |
| "Central pontine and extrapontine myelinolysis (CPEM) are rare conditions usually associated with rapid correction of hyponatremia." | 1.34 | Psychotic disorder in a patient with central and extrapontine myelinolysis. ( Krystal, A; Lim, L, 2007) |
| " Although directly related to daily dosage of levodopa, the myoclonus was specifically blocked by the serotonin antagonist, methysergide." | 1.25 | Levodopa-induced myoclonus. ( Bergen, D; Goetz, C; Klawans, HL, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (80.00) | 18.7374 |
| 1990's | 4 (8.89) | 18.2507 |
| 2000's | 2 (4.44) | 29.6817 |
| 2010's | 3 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bamford, A | 1 |
| Crowe, BH | 1 |
| Hacohen, Y | 1 |
| Lin, JP | 1 |
| Clarke, A | 1 |
| Tudor-Williams, G | 1 |
| Sancho-Shimizu, V | 1 |
| Vincent, A | 1 |
| Lim, M | 1 |
| Pullaperuma, SP | 1 |
| Ben-Pazi, H | 1 |
| Rubio-Agusti, I | 1 |
| Carecchio, M | 1 |
| Bhatia, KP | 1 |
| Kojovic, M | 1 |
| Parees, I | 1 |
| Chandrashekar, HS | 1 |
| Footitt, EJ | 1 |
| Burke, D | 1 |
| Edwards, MJ | 1 |
| Lachmann, RH | 1 |
| Murphy, E | 1 |
| Sanger, TD | 1 |
| ABRAMCZUK, J | 1 |
| DRAPER, IT | 1 |
| JOHNS, RJ | 1 |
| Lim, L | 1 |
| Krystal, A | 1 |
| Heath, DA | 1 |
| McGarry, JM | 1 |
| Nakamura, S | 1 |
| Akiguchi, I | 1 |
| Noda, K | 1 |
| Isozaki, E | 1 |
| Miyamoto, K | 1 |
| Hirose, K | 1 |
| Tanabe, H | 1 |
| Oda, M | 1 |
| Weitzman, DO | 1 |
| Rosfnfeld, C | 1 |
| Korenyl, C | 1 |
| Whittier, JR | 1 |
| Drobný, M | 1 |
| Adamkov, J | 1 |
| Svaleková, A | 1 |
| Fundárek, J | 1 |
| Ohtomo, E | 1 |
| Klawans, HL | 1 |
| Goetz, C | 1 |
| Bergen, D | 1 |
| Stimmel, GL | 1 |
| Sandyk, R | 1 |
| Fahn, S | 1 |
| Burke, R | 1 |
| Stern, Y | 1 |
| Jabbari, B | 1 |
| Scherokman, B | 1 |
| Gunderson, CH | 1 |
| Rosenberg, ML | 1 |
| Miller, J | 1 |
| Yamamoto, K | 1 |
| Noda, S | 1 |
| Umezaki, H | 1 |
| Hirata, I | 1 |
| Oda, K | 1 |
| Kuroda, Y | 1 |
| Shibasaki, H | 1 |
| Kihara, H | 1 |
| Valente, M | 1 |
| Porter, MT | 1 |
| Fluharty, AL | 1 |
| Mano, T | 1 |
| Birket-Smith, E | 1 |
| Jurna, I | 2 |
| Lanzer, G | 1 |
| Theres, C | 1 |
| Bachmann, T | 1 |
| Chase, TN | 1 |
| Bordeleau, JM | 1 |
| Tétreault, L | 1 |
| Grove, L | 1 |
| Crammer, JL | 1 |
| Klett, CJ | 1 |
| Caffey, E | 1 |
| Turek, I | 1 |
| Kurland, AA | 1 |
| Hanlon, TE | 1 |
| Bohm, M | 1 |
| Wolf, SM | 1 |
| Crane, GE | 1 |
| Parkes, JD | 1 |
| Baxter, RC | 1 |
| Marsden, CD | 1 |
| Rees, JE | 1 |
| Bastecký, J | 1 |
| Vinar, O | 1 |
| Taussigová, D | 1 |
| Villeneuve, A | 1 |
| Schieferstein, GJ | 1 |
| Kaufmann, W | 1 |
| Butz, P | 1 |
| Wiesendanger, M | 1 |
| Yaryura-Tobias, JA | 1 |
| Wolpert, A | 1 |
| Dana, L | 1 |
| Merlis, S | 1 |
| Kline, NS | 1 |
| Guggenheim, MA | 1 |
| Dodge, PR | 1 |
| Weintraub, MI | 1 |
| Van Woert, MH | 1 |
| Maller, O | 1 |
| Heller, S | 1 |
| Roy, P | 1 |
| St-Jean, A | 1 |
| Ban, T | 1 |
| Noe, W | 1 |
| Meyer, HH | 1 |
| Grabowski, K | 1 |
4 reviews available for trihexyphenidyl and Movement Disorders
| Article | Year |
|---|---|
Pediatric movement disorders.
Topics: Anticonvulsants; Antiparkinson Agents; Child; Humans; Movement Disorders; Muscle, Skeletal; Trihexyp | 2003 |
[Oral dyskinesis, facial dystonia].
Topics: Dyskinesia, Drug-Induced; Dystonia; Face; Female; Humans; Levodopa; Male; Meige Syndrome; Mouth; Mov | 1993 |
Antimuscarinic drugs in the treatment of movement disorders.
Topics: Adult; Attention; Dystonia; Humans; Memory; Movement Disorders; Parasympatholytics; Parkinson Diseas | 1990 |
Drug-induced extrapyramidal disorders.
Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopa | 1972 |
3 trials available for trihexyphenidyl and Movement Disorders
| Article | Year |
|---|---|
Benzhexol and side effects with long-acting fluphenazine therapy.
Topics: Administration, Oral; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Female; Fluphen | 1972 |
Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
Topics: 1-Propanol; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Benztropine; Biperiden; Chronic Dis | 1972 |
Neutralization of extrapyramidal side-effects with Methixene.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Extrapyramidal Tracts; Female; Humans; Male; Middle Age | 1971 |
38 other studies available for trihexyphenidyl and Movement Disorders
| Article | Year |
|---|---|
Pediatric Herpes Simplex Virus Encephalitis Complicated by N-Methyl-D-aspartate Receptor Antibody Encephalitis.
Topics: Acyclovir; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiviral Agents; Autoantibodies; Clonid | 2015 |
Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis.
Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Female; Humans; Infant; Male; Motor Activity; M | 2011 |
Movement disorders in adult patients with classical galactosemia.
Topics: Adult; Anti-Dyskinesia Agents; Benzamides; Botulinum Toxins; Brain; Cross-Sectional Studies; Databas | 2013 |
[On the appearance of acathisia during neuroleptic therapy].
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Movement; Movement Disorders; Psychiatric Somatic Ther | 1960 |
THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.
Topics: Atropine; Dextroamphetamine; Diphenhydramine; Drug Therapy; Geriatrics; Humans; Kinetics; Motor Skil | 1964 |
Psychotic disorder in a patient with central and extrapontine myelinolysis.
Topics: Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Baclofen; Fema | 2007 |
Phenothiazines in early labour.
Topics: Adult; Diagnosis, Differential; Female; Humans; Hyperemesis Gravidarum; Movement Disorders; Perphena | 1967 |
[Rhythmical involuntary movement at rest associated with olivo-ponto-cerebellar atrophy (OPCA)].
Topics: Adolescent; Aged; Brain; Clonazepam; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; | 1993 |
Quantification of chorea in Huntington's disease by power spectral analysis.
Topics: Adult; Aged; Diazepam; Haloperidol; Humans; Huntington Disease; Mesoridazine; Methods; Middle Aged; | 1976 |
[Therapy of rigidity and hypokinesis in old age using Sinemet].
Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; | 1979 |
[Oral dyskinesia (author's transl)].
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Masticatory Muscles; Movement Disord | 1976 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose | 1975 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloper | 1976 |
Alpha-melanocyte-stimulating hormone: possible role in the pathophysiology of acute drug-induced dystonia.
Topics: alpha-MSH; Child; Dermatitis, Seborrheic; Dyskinesia, Drug-Induced; Female; Humans; Hydroxyzine; Mov | 1990 |
Treatment of movement disorders with trihexyphenidyl.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Movement Disorders; Trihexyphenidyl | 1989 |
[Parkinson's disease associated with trihexyphenidyl (THP) induced dysphonia plicae ventricularis].
Topics: Aged; Female; Humans; Movement Disorders; Parkinson Disease; Sulpiride; Tongue Diseases; Trihexyphen | 1988 |
[Trihexyphenidyl (THP)-induced respiratory dyskinesia].
Topics: Humans; Male; Middle Aged; Movement Disorders; Respiration Disorders; Trihexyphenidyl | 1986 |
Hyperdibasicaminoaciduria in a mentally retarded homozygote with a peculiar response to phenothiazines.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Antipsychotic Agents; Arginine; Chlorpromazine; Cy | 1973 |
[Dyskinesia induced by anticholinergic drugs--electrophysiological analysis].
Topics: Aged; Benztropine; Biperiden; Electromyography; Female; Humans; Male; Middle Aged; Movement Disorder | 1974 |
Abnormal involuntary movements induced by anticholinergic therapy.
Topics: Aged; Biperiden; Dibenzazepines; Female; Humans; Mastication; Middle Aged; Movement Disorders; Orphe | 1974 |
Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Cyclohexanes; Cyclopentanes; Depression, Chemical; Dihydro | 1969 |
The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Dihydroxyphenylalanine; Electric Stimulation; Electromyogr | 1969 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperid | 1972 |
Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.
Topics: Aged; Chronic Disease; Female; Humans; Intellectual Disability; Male; Middle Aged; Movement Disorder | 1972 |
Reserpine: cause and treatment of oral-facial dyskinesia.
Topics: Deglutition Disorders; Diazepam; Face; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged | 1973 |
Rapid reversal of tardive dyskinesia.
Topics: Adult; Chlorpromazine; Dibenzoxepins; Female; Haloperidol; Humans; Movement Disorders; Neurologic Ma | 1973 |
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
Topics: Aged; Amantadine; Cognition Disorders; Dihydroxyphenylalanine; Drug Therapy, Combination; Edema; Eye | 1974 |
Extrapyramidal symptoms in the course of fluphenazine treatment.
Topics: Adult; Basal Ganglia Diseases; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Move | 1972 |
The rabbit syndrome. A peculiar extrapyramidal reaction.
Topics: Aged; Anxiety; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Fatigue; Female; Humans; Male; M | 1972 |
Central anticholinergic activity of: 2,2-diphenyl-4(3-azabicyclo (3-2-2) non-3-yl) butyramide hydrochloride (SC-13639).
Topics: Animals; Bridged-Ring Compounds; Central Nervous System; Drug Antagonism; Male; Mice; Motor Activity | 1972 |
[Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
Topics: Aged; Carboxy-Lyases; Desipramine; Dihydroxyphenylalanine; Discrimination, Psychological; Drug Syner | 1969 |
Action of L-Dopa in drug induced extrapyramidalism.
Topics: Adult; Chlorpromazine; Chronic Disease; Dihydroxyphenylalanine; Extrapyramidal Tracts; Female; Human | 1970 |
Greater than recommended drug dosages--some effects.
Topics: Adult; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Movement Disorders; Procyclidine; | 1970 |
Unusual arm movements with onset in childhood--a nosologic entity?
Topics: Child; Diagnosis, Differential; Diazepam; Dihydroxyphenylalanine; Diphenhydramine; Dystonia Musculor | 1970 |
Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
Topics: Brain; Dihydroxyphenylalanine; Dopamine; Drug Hypersensitivity; Female; Handwriting; Humans; Injecti | 1971 |
Studies with antiparkinsonian drugs with chronic psychiatric patients.
Topics: Adult; Aged; Chlorpromazine; Extrapyramidal Tracts; Humans; Mental Disorders; Middle Aged; Movement | 1966 |
[On the question of possible irreversible disorders due to psychopharmacotherapy].
Topics: Adult; Autonomic Nervous System; Biperiden; Butyrophenones; Central Nervous System; Chlorpromazine; | 1966 |
[Prolonged use of ponalid in extapyramidal drug-induced syndromes].
Topics: Humans; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Salivary Gland Diseases | 1966 |